dc.contributor.author | Baykan Baykal, Betul | |
dc.contributor.author | Kocaman, Gulsen | |
dc.contributor.author | Gulsen, Yesim | |
dc.contributor.author | Ertas, Mustafa | |
dc.contributor.author | Bilgic, Basar | |
dc.contributor.author | Kahraman, Nese | |
dc.contributor.author | Gurkan Koseoglu, Banu | |
dc.contributor.author | Matur, Zeliha | |
dc.date.accessioned | 2021-03-05T18:18:08Z | |
dc.date.available | 2021-03-05T18:18:08Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Kocaman G., Kahraman N., Gurkan Koseoglu B., Bilgic B., Matur Z., Ertas M., Gulsen Y., Baykan Baykal B., "Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders", NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, cilt.55, ss.330-336, 2018 | |
dc.identifier.issn | 1300-0667 | |
dc.identifier.other | av_c9afe927-7ac6-4166-96d3-417688104022 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/133629 | |
dc.identifier.uri | https://doi.org/10.5152/npa.2017.19257 | |
dc.description.abstract | Introduction: Migraine and temporomandibular disorders (TMD) are both common diseases and TMD are reported as a risk factor in migraine progression. OnabotulinumtoxinA is used in the treatment of chronic migraine (CM), and also has a potential role in TMD treatment. In this study, it is aimed to compare the efficacy of onabotulinumtoxinA treatment in CM patients with and without TMD. | |
dc.language.iso | eng | |
dc.subject | Nöroloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.title | Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders | |
dc.type | Makale | |
dc.relation.journal | NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 55 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 330 | |
dc.identifier.endpage | 336 | |
dc.contributor.firstauthorID | 258962 | |